Back to search

Article

TMED9 is a Predictive Marker of Transition from Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

2022-12-15

Abstract excerpt

<h4>Purpose: </h4> Plasma Cell Dyscrasias are a heterogeneous group of hematological diseases. The candidate ten genes identified from our transcriptome data are highly valuable and specific. <h4>Methods: </h4>: We investigated the prognostic biomarker status of these genes in Plasma Cell Dyscrasias. Expression levels of ISG20, EEF2, TRIB1, RRBP1, TMED9, KDELR1, DNAJC1, DPP7, COPE and LMAN2 genes were measured via...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d402ebfe-add6-559a-8b90-6def2b870efa
DOI
10.21203/rs.3.rs-2370302/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TMED9 is a Predictive Marker of Transition from Monoclonal Gammopathy of Undetermined Significance to Multiple MyelomaDOI 10.21203/rs.3.rs-2370302/v1
Select a neighboring publication to make it the new centre.